Rezield

AstraZeneca Learns the FDA May Have Gotten Wise to Copy-Cat Drugs
BNET Pharma
Mon, 06/7/10 - 07:55 am
AstraZeneca
FDA
copycat drugs
RSV
Synagis
Rezield